RA Capital Healthcare Fund, 10% Owner: Enliven Therapeutics ELVN Buy · Filed 23/01/05

Trade details

Type: Insider buy
Amount: $2,517,188
Shares · price: 629,297 sh · $4.00 a share
Held after: 3,880,021 sh
Stock: Enliven Therapeutics ELVN
Person: RA Capital Healthcare Fund10% Owner
Trade date: 23/01/03
Filed: 23/01/05
Days to filing: 2 days

4 insiders bought this week

Insiders buying this week: 4 insiders
Holding change: +19.4%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 22/12/04~23/02/02

RA Capital Healthcare Fund's recent trades

RA Capital Healthcare FundDirector, 10% Stockholder
Planned saleSionna Therapeutics
Planned sale
Sionna Therapeutics
SION
$21.8M
3,448,811 sh
$21.8M
Filed 09/17
Traded 09/17
RA Capital Healthcare FundDirector
Planned saleSepterna
Planned sale
Septerna
SEPN
$36M
746,500 sh
$36M
Filed 08/12
Traded 08/12
RA Capital Healthcare FundDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$275.3K
31,000 sh
$275.3K
Filed 06/29
Traded 06/25
RA Capital Healthcare FundDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$16.8K
1,876 sh
$16.8K
Filed 06/29
Traded 06/26
RA Capital Healthcare Fund10% Owner
SellWerewolf Therapeutics
Sell
Werewolf Therapeutics
HOWL
$136.2K
389,216 sh
$136.2K
Filed 06/22
Traded 06/17

RA Capital Healthcare Fund, 10% Owner — bought $2.5M of Enliven Therapeutics ELVN · 629,297 sh @ $4.00 | Whalegun